Literature DB >> 30390038

Neuroendocrine neoplasia goes molecular - time for a change.

Guido Rindi1, Bertram Wiedenmann2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30390038     DOI： 10.1038/s41571-018-0118-8

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  2 in total

1.  Unmet Needs in Functional and Nonfunctional Pancreatic Neuroendocrine Neoplasms.

Authors:  Robert T Jensen; Lisa Bodei; Jaume Capdevila; Anne Couvelard; Massimo Falconi; Simona Glasberg; Günter Kloppel; Steven Lamberts; Marc Peeters; Guido Rindi; Anja Rinke; Mathias Rothmund; Anders Sundin; Staffan Welin; Nicola Fazio
Journal:  Neuroendocrinology       Date:  2018-10-03       Impact factor: 4.914

2.  Modulation of Premetastatic Niche by the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Localized High-Risk Prostate Cancer Followed by Radical Prostatectomy: A Phase II Randomized Trial.

Authors:  Benjamin L Maughan; Sumanta K Pal; David Gill; Kenneth Boucher; Christopher Martin; Meghan Salgia; Roberto Nussenzveig; Ting Liu; Josiah L Hawks; Julia Batten; Gayatri Nachaegari; Robert Stephenson; William Lowrance; Jeremy Jones; Christopher Dechet; Neeraj Agarwal
Journal:  Oncologist       Date:  2018-11-01
  2 in total
  4 in total

1.  Highly variable biodistribution of 68Ga labeled somatostatin analogues 68Ga-DOTA-NOC and 68Ga-DOTA-TATE in neuroendocrine tumors: clinical implications for somatostatin receptor directed PET/CT.

Authors:  Monica Cheng; Mark Tann
Journal:  Hepatobiliary Surg Nutr       Date:  2022-10       Impact factor: 8.265

Review 2.  Neuroendocrine neoplasia of the gastrointestinal tract revisited: towards precision medicine.

Authors:  Guido Rindi; Bertram Wiedenmann
Journal:  Nat Rev Endocrinol       Date:  2020-08-24       Impact factor: 43.330

3.  The histone deacetylase inhibitor PCI-24781 impairs calcium influx and inhibits proliferation and metastasis in breast cancer.

Authors:  Tianshu Yang; Pei Wang; Xin Yin; Jingyao Zhang; Miaomiao Huo; Jie Gao; Gen Li; Xu Teng; Hefen Yu; Wei Huang; Yan Wang
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

Review 4.  Circulating Neuroendocrine Tumor Biomarkers: Past, Present and Future.

Authors:  Paweł Komarnicki; Jan Musiałkiewicz; Alicja Stańska; Adam Maciejewski; Paweł Gut; George Mastorakos; Marek Ruchała
Journal:  J Clin Med       Date:  2022-09-21       Impact factor: 4.964
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.